Bank of America’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.41M | Sell |
799,502
-109,046
| -12% | -$465K | ﹤0.01% | 3620 |
|
|
2025
Q1 | $3.42M | Buy |
908,548
+43,209
| +5% | +$162K | ﹤0.01% | 3530 |
|
|
2024
Q4 | $5.04M | Buy |
865,339
+454,400
| +111% | +$2.65M | ﹤0.01% | 3024 |
|
|
2024
Q3 | $4.91M | Buy |
410,939
+277,544
| +208% | +$3.31M | ﹤0.01% | 3198 |
|
|
2024
Q2 | $1.44M | Sell |
133,395
-193,424
| -59% | -$2.09M | ﹤0.01% | 3970 |
|
|
2024
Q1 | $3.7M | Buy |
326,819
+286,709
| +715% | +$3.25M | ﹤0.01% | 3285 |
|
|
2023
Q4 | $563K | Buy |
40,110
+2,227
| +6% | +$31.2K | ﹤0.01% | 4544 |
|
|
2023
Q3 | $468K | Buy |
37,883
+15,604
| +70% | +$193K | ﹤0.01% | 4527 |
|
|
2023
Q2 | $201K | Sell |
22,279
-7,114
| -24% | -$64.2K | ﹤0.01% | 4998 |
|
|
2023
Q1 | $102K | Buy |
29,393
+1,042
| +4% | +$3.62K | ﹤0.01% | 5456 |
|
|
2022
Q4 | $69.5K | Buy |
28,351
+14,467
| +104% | +$35.4K | ﹤0.01% | 5610 |
|
|
2022
Q3 | $38K | Sell |
13,884
-39,896
| -74% | -$109K | ﹤0.01% | 5946 |
|
|
2022
Q2 | $219K | Sell |
53,780
-102,202
| -66% | -$416K | ﹤0.01% | 5280 |
|
|
2022
Q1 | $664K | Buy |
155,982
+40,816
| +35% | +$174K | ﹤0.01% | 4918 |
|
|
2021
Q4 | $1.08M | Buy |
115,166
+89,864
| +355% | +$841K | ﹤0.01% | 4457 |
|
|
2021
Q3 | $698K | Buy |
25,302
+21,545
| +573% | +$594K | ﹤0.01% | 4614 |
|
|
2021
Q2 | $105K | Sell |
3,757
-23,659
| -86% | -$661K | ﹤0.01% | 5714 |
|
|
2021
Q1 | $910K | Buy |
27,416
+27,321
| +28,759% | +$907K | ﹤0.01% | 4332 |
|
|
2020
Q4 | $5K | Buy |
+95
| New | +$5K | ﹤0.01% | 6043 |
|